Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01601548 · ClinicalTrials.gov registry record · NA

Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy

A NA study, sponsored by Masonic Cancer Center, University of Minnesota.

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT01601548 is a NA study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01601548, a NA study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

Upon the completion of aggressive chemotherapy and radiation for curative intent cancers, many cancer survivors suffer from a myriad of symptoms ranging from physical symptoms such as hot flashes, insomnia, and fatigue to psychosocial symptoms including depression and anxiety. Mindfulness Based Cancer Recovery (MBCR) is a type of mind-body intervention. Mind-body interventions are defined as practices or interventions that focus on the connection and integration of the mind and body and the ability for these connections to effect changes on physical, emotional and spiritual levels for the purpose of promoting health and well being.

Interventions

  • BEHAVIORAL Mindfulness Based Cancer Recovery

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2012-07
Est. Completion 2013-07
Phase NA

What the Registry Record Tells You About NCT01601548

The ClinicalTrials.gov registry entry for NCT01601548 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mindfulness Based Cancer Recovery is the first listed.

NCT01601548 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01601548 about?

NCT01601548 is a clinical study titled "Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy". Upon the completion of aggressive chemotherapy and radiation for curative intent cancers, many cancer survivors suffer from a myriad of symptoms ranging from physical symptoms such as hot flashes, insomnia, and fatigue to psychosocial symptoms including depression and anxiety. Mindfulness Based Canc...

What is the current status of trial NCT01601548?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2012-07. Estimated completion is 2013-07.

What interventions are being tested in trial NCT01601548?

The interventions under investigation include: Mindfulness Based Cancer Recovery (BEHAVIORAL).

Who is sponsoring clinical trial NCT01601548?

This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.